In phases I and II clinical trials of new TB vaccines, the frequencies of vaccine-induced antigen-specific T helper type 1 (Th1) cytokine-expressing CD4+ and/or CD8+ T cells are usually quantified with the premise that vaccination-induced responses should be higher than the prevaccination response [7]. This evidence concerns the gene CD4 and tuberculosis.